Literature DB >> 18341202

Mycobacterium tuberculosis and dendritic cells: recognition, activation and functional implications.

Aprajita Sinha1, Nasir Salam, Shashank Gupta, Krishnamurthy Natarajan.   

Abstract

The highly complex nature of interactions of Mycobacterium tuberculosis with cells of the immune system has puzzled researchers the world-over in understanding the pathogenesis and immunology associated with tuberculosis (TB). This has contributed to the delay in development of effective vaccine(s) for TB. Several excellent studies have provided only a glimpse of the kind and degree of immune responses elicited following infection by mycobacteria. Preferred entry via respiratory route results in the capture of mycobacteria by alveolar macrophages that eventually become their long-term hosts. Since the pathogen is rarely cleared this has resulted in the human population serving as a large reservoir for mycobacteria. Owing to their unique ability to prime naïve and memory T cells, dendritic cells (DCs) play important and indispensable roles in the initiation and maintenance of protective immune responses following infection. The kind of immune response initiated by DCs with respect to mycobacteria determines the character of immune responses mounted by the host against the pathogen. The profile of cytokines and chemokines secreted as a result of infection of DCs by mycobacteria further plays an important role in defining the course of infection. This minireview attempts to highlight key interactions of mycobacteria with dendritic cells. We discus the uptake of mycobacteria by DCs followed by DC activation and the spectrum of immune responses initiated by infected/activated DCs, followed by numerous ways the pathogen has devised to subvert protective responses.

Entities:  

Mesh:

Year:  2007        PMID: 18341202

Source DB:  PubMed          Journal:  Indian J Biochem Biophys        ISSN: 0301-1208            Impact factor:   1.918


  6 in total

1.  Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberculosis.

Authors:  Shashank Gupta; Kathryn Winglee; Richard Gallo; William R Bishai
Journal:  J Pathol       Date:  2017-03-15       Impact factor: 7.996

2.  Respiratory infection: insights from assembly 10 of the European Respiratory Society 2018 Annual Congress.

Authors:  Cristina Calarasu; Aran Singanayagam
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  Rv0315, a novel immunostimulatory antigen of Mycobacterium tuberculosis, activates dendritic cells and drives Th1 immune responses.

Authors:  Eui-Hong Byun; Woo Sik Kim; A-Rum Shin; Jong-Seok Kim; Jake Whang; Choul-Jae Won; Yohan Choi; Su-Young Kim; Won Jung Koh; Hwa-Jung Kim; Sung Jae Shin
Journal:  J Mol Med (Berl)       Date:  2011-10-13       Impact factor: 4.599

4.  Simian virus 40 inhibits differentiation and maturation of rhesus macaque DC-SIGN(+) dendritic cells.

Authors:  C Changyong; M Sun; H Li; N Brockmeyer; Nan Ping Wu
Journal:  Eur J Med Res       Date:  2010-09-24       Impact factor: 2.175

Review 5.  Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis?

Authors:  Juan I Moliva; Joanne Turner; Jordi B Torrelles
Journal:  Front Immunol       Date:  2017-04-05       Impact factor: 7.561

6.  Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice.

Authors:  Han-Gyu Choi; Seunga Choi; Yong Woo Back; Seungwha Paik; Hye-Soo Park; Woo Sik Kim; Hongmin Kim; Seung Bin Cha; Chul Hee Choi; Sung Jae Shin; Hwa-Jung Kim
Journal:  Oncotarget       Date:  2017-03-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.